CD14 and melanoma: Dissecting the molecular properties of tumor-conditioned CD14+ cells, a panel of specific miRNAs was found to associate with the immunosuppressive and pro-inflammatory functions of MDSCs and to predict resistance to ICPi, but not TKI in melanoma patients.